Award
Delivery Order #SPE2DP26F2974
Delivery Order for Meclizine Hydrochloride Under Pharmaceutical Supply IDV
Buyer
Defense Logistics Agency
Award Amount
$3.56
Ceiling
$3.56
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Mar 09, 2026
Identifier
SPE2DP26F2974
NAICS
424210
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a specialized distributor in pharmaceutical products. It is a child award under a broader definitive pharmaceutical supply contract IDV, through which DMS supplies critical medications to federal health agencies. The contract procures Meclizine Hydrochloride, a pharmaceutical product used for specific medical treatments. This delivery order supports the agency's ongoing public health efforts by ensuring timely availability of essential drugs. The scope covers the supply and delivery of Meclizine Hydrochloride to a specified location in Park Ridge, Illinois. The award follows the framework established under the parent IDV, which was competitively procured to maintain a steady and reliable pharmaceutical supply chain. The performance period for this delivery order is short-term, spanning a few weeks in early 2026. This task order exemplifies the continuing relationship between the federal agency and DMS Pharmaceutical Group, reinforcing the importance of dependable pharmaceutical logistics in federal health initiatives.
Description
8511936257!MECLIZINE HYDROCHLO